Graphite Bio Announces Participation in Upcoming Jefferies Gene Therapy/Editing Summit
October 21 2021 - 8:00AM
Business Wire
Graphite Bio, Inc. (Nasdaq: GRPH), a clinical-stage,
next-generation gene editing company focused on therapies that
harness targeted gene integration to treat or cure serious
diseases, announced today that members of the management team will
participate in a fireside chat at the Jefferies Gene
Therapy/Editing Summit on Thursday, Oct. 28, 2021, at 4:30 p.m.
ET.
The fireside chat will be webcast live from Graphite Bio’s
website at www.graphitebio.com in the Investors section. A replay
of the webcast will be archived and available for one month
following the event.
About Graphite Bio
Graphite Bio is a clinical-stage, next-generation gene editing
company harnessing high efficiency targeted gene integration to
develop a new class of therapies to potentially cure a wide range
of serious and life-threatening diseases. Graphite Bio is
pioneering a precision gene editing approach that could enable a
variety of applications to transform human health through its
potential to achieve one of medicine’s most elusive goals: to
precisely “find & replace” any gene in the genome. Graphite
Bio’s platform allows it to precisely correct mutations, replace
entire disease-causing genes with normal genes or insert new genes
into predetermined, safe locations. The company was co-founded by
academic pioneers in the fields of gene editing and gene therapy,
including Maria Grazia Roncarolo, M.D., and Matthew Porteus, M.D.,
Ph.D.
Learn more about Graphite Bio by visiting www.graphitebio.com
and following the company on LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211021005108/en/
Company: Stephanie Yao VP, Communications and Investor
Relations 443-739-1423 syao@graphitebio.com
Investor Relations: Stephanie Ascher Stern IR, Inc.
212-362-1200 ir@graphitebio.com
Media: Christy Curran Sam Brown, Inc. 615-414-8668
media@graphitebio.com
Graphite Bio (NASDAQ:GRPH)
Historical Stock Chart
From May 2024 to Jun 2024
Graphite Bio (NASDAQ:GRPH)
Historical Stock Chart
From Jun 2023 to Jun 2024